51
|
Amoura A, Cohen Aubart F, Barète S, Charlotte F, Emile J, Lebrun-Vignes B, Mathian A, Benameur N, Haroche J, Amoura Z. Sarcoïdose survenant sous traitement par inhibiteur de BRAF : description de 3 cas et revue systématique de la littérature. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
52
|
Chérin P, Aubart FC, Mathian A, Haroche J, Amoura Z. Évaluation de la fonction rénale sous immunoglobulines sous-cutanées à forte dose chez 20 patients traités pour myosite. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
53
|
Chazal T, Chérin P, Hie M, Haroche J, Aubart FC, Mathian A, Pha M, Amoura Z. Premier cas décrit d’une dermatomyosite avec calcinose compliquée d’une myosite ossifiante. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
54
|
Parreau S, Haroche J, Pommepuy I, Emile J, Archambeaud F. Histiocytose mixte, BRAF V600E mutée. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
55
|
Cohen Aubart F, Galanaud D, Haroche J, Psimaras D, Mathian A, Hié M, Le-Thi Huong Boutin D, Charlotte F, Maillart E, Maisonobe T, Amoura Z. [Neurosarcoidosis: Diagnosis and therapeutic issues]. Rev Med Interne 2016; 38:393-401. [PMID: 27884456 DOI: 10.1016/j.revmed.2016.10.392] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2016] [Revised: 08/17/2016] [Accepted: 10/24/2016] [Indexed: 12/15/2022]
Abstract
Neurological localizations of sarcoidosis are heterogeneous and may affect virtually every part of the central or peripheral nervous system. They are often the inaugural manifestation of sarcoidosis. The diagnosis may be difficult due to the lack of extra-neurological localization. Diagnosis may be discussed in the presence of an inflammatory neurological disease, in particular in case of suggestive radiological or biological pattern. Cerebrospinal fluid analysis shows lymphocytic pleiocytosis, often with low glucose level. The diagnosis relies on a clinical, biological and radiological presentation consistent with neurosarcoidosis, the presence of non-caseating granuloma and exclusion of differential diagnoses. Screening for other localizations of sarcoidosis, in particular cardiac disease may be obtained during neurosarcoidosis. The treatment of neurosarcoidosis relies on corticosteroids although immunosuppressive drugs are usually added because of the chronic course of this condition and to limit the side effects of steroids. Treatments and follow-up may be prolonged because of the high rate of relapses.
Collapse
|
56
|
Cohen Aubart F, Nunes H, Mathian A, Haroche J, Hié M, Le-Thi Huong Boutin D, Cluzel P, Soussan M, Waintraub X, Fouret P, Valeyre D, Amoura Z. [Cardiac sarcoidosis: Diagnosis and therapeutic challenges]. Rev Med Interne 2016; 38:28-35. [PMID: 27211064 DOI: 10.1016/j.revmed.2016.03.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2015] [Revised: 03/06/2016] [Accepted: 03/14/2016] [Indexed: 12/16/2022]
Abstract
Sarcoidosis is a granulomatous disorder of unknown cause characterized by non-caseating granuloma in young adults. Cardiac involvement is rare and range from 2 to 75% depending on diagnostic criteria. Cardiac involvement in sarcoidosis may be asymptomatic or may manifest as rhythm/conduction troubles or congestive heart failure. The diagnosis and treatment of cardiac sarcoidosis may be challenging. However, advances have come in recent years from the use of cardiac MRI and 18FDG-TEP scanner, as well as from the stratification of the risk of ventricular tachycardia/fibrillation. Due to the rarity of the disease, there is no reliable prospective large study to guide therapeutic strategy for cardiac sarcoidosis. Corticosteroids are probably efficacious, in particular in case of atrio-ventricular block or moderate heart failure. Immunosuppressive drugs have not been largely studied but methotrexate could be helpful. In refractory forms, TNF-α antagonists have been used with success.
Collapse
|
57
|
Cohen Aubart F, Haroche J, Grenier P, Maurier F, Hervier B, Prévot G, Bulifon S, Nunes H, Amoura Z. Les atteintes pleuropulmonaires sont un facteur pronostique de la survie au cours de la maladie d’Erdheim-Chester. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
58
|
Rozban Y, Devilliers H, Hie M, Pha M, Mathian A, Aubart FC, Haroche J, Hulot J, Zahr N, Amoura Z. Facteurs associés à une adhésion thérapeutique médiocre au cours du lupus systémique. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
59
|
Mathian A, Dorgham K, Aubart FC, Hie M, Haroche J, Pha M, Jacob C, Rozenberg F, Yssel H, Gorochov G, Amoura Z. Caractérisation des sous-types d’interféron-alpha dans le lupus systémique. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
60
|
Lhote R, Cohen Aubart F, Grenier P, Miyara M, Haroche J, Mathian A, Hie M, Boutin D, Musset L, Amoura Z. Atteintes pulmonaires associées à l’anticorps anti-RNP : étude de 190 patients. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
61
|
Van Meerhaeghe T, Mathian A, Wargny M, Pha M, Hie M, Haroche J, Aubart FC, Amoura Z. Évaluation du risque cardiovasculaire au cours du lupus systémique : résultats préliminaires d’une cohorte française de 159 patients. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
62
|
Huscenot T, Mathian A, Pha M, Cohen Aubart F, Deligny C, Haroche J, Hie M, Samson M, Devilliers H, Besancenot J, Bonnotte B, Amoura Z. Survenue d’un lymphome au cours du lupus systémique : description d’une série de 14 patients. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
63
|
Bitoun S, Bernardino V, Cohen Aubart F, Hervier B, Haroche J, Mathian A, Hie M, Boutin D, Lamaury I, Grenier P, Amoura Z. Efficacité et tolérance du mycophénolate mofétil dans les atteintes pulmonaires du syndrome des antisynthétases. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
64
|
Rozban Y, Hie M, Devilliers H, Pha M, Mathian A, Aubart FC, Haroche J, Hulot J, Zahr N, Amoura Z. Le BMQ spécifique permet de prédire l’adhésion thérapeutique à l’hydroxychloroquine au cours du lupus systémique. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
65
|
Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z. Prévention des infections au cours du lupus systémique chez l’adulte et l’adolescent : élaboration de recommandations pour la pratique clinique, à partir d’une analyse de la littérature et de l’avis d’experts. Rev Med Interne 2016; 37:307-20. [DOI: 10.1016/j.revmed.2016.01.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2015] [Revised: 01/03/2016] [Accepted: 01/05/2016] [Indexed: 12/21/2022]
|
66
|
Courtillot C, Laugier Robiolle S, Cohen Aubart F, Leban M, Renard-Penna R, Drier A, Charlotte F, Amoura Z, Touraine P, Haroche J. Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim-Chester Disease. J Clin Endocrinol Metab 2016; 101:305-13. [PMID: 26565949 DOI: 10.1210/jc.2015-3357] [Citation(s) in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
CONTEXT Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis, characterized by infiltration of foamy histiocytes in multiple organs. Endocrine involvement has mostly been described in case reports. OBJECTIVE We performed systematic endocrine evaluation in a large cohort of patients with ECD. DESIGN This was a single-center observational study conducted between October 2007 and May 2013. SETTING The evaluation was conducted in Pitié-Salpêtrière Hospital (Paris, France), a tertiary care hospital. PATIENTS Sixty-four consecutive patients with ECD (sex ratio, 3.6; mean age, 57.6 years [range, 20-80 years]). Thirty-six patients had follow-up assessments. INTERVENTIONS There were no interventions. MAIN OUTCOME MEASURES Clinical, biological, and morphological evaluations of pituitary, gonadal, adrenal, and thyroid functions, as well as metabolic evaluation, were performed. RESULTS Diabetes insipidus was found in 33.3% of patients, frequently as the first manifestation of ECD. Anterior pituitary dysfunction was found in 91.3% of patients with full anterior pituitary evaluation, including somatotropic deficiency (78.6%), hyperprolactinemia (44.1%), gonadotropic deficiency (22.2%), thyrotropic deficiency (9.5%), and corticotropic deficiency (3.1%). Thirty-five patients (54.7%) had ≥2 anterior pituitary dysfunctional axes, rising to 69.6% (16 of 23) when only patients with complete evaluations were considered. Two patients had panhypopituitarism. Infiltration of the pituitary and stalk was found with magnetic resonance imaging in 24.4% of patients. Testicular insufficiency was found in 53.1% of patients, with sonographic testicular infiltration in 29% of men, mostly bilateral. Computed tomography adrenal infiltration was found in 39.1% of patients, and 1 case of adrenal insufficiency was observed. No patient was free of endocrine hormonal or morphological involvement. Endocrine dysfunctions were most often permanent, and new deficits appeared during follow-up. CONCLUSION Endocrine involvement is very frequent in ECD and should be evaluated carefully at diagnosis and during follow-up.
Collapse
|
67
|
Cohen Aubart F, Haroche J, Emile J, Fuzibet J, Granel B, Grosbois B, Ly K, Lazaro E, Saadoun D, Maurier F, Raffray L, Amoura Z. Les patients ayant une maladie d’Erdheim-Chester avec mutation BRAF V600E ont un profil cardiovasculaire plus marqué que ceux non mutés. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
68
|
Rivière E, Maisonobe T, Maurier F, Richez C, Gombert B, Gousseff M, Chaib A, Mathian A, Hie M, Haroche J, Amoura Z, Cohen Aubart F. Mononeuropathie multiple au cours du lupus systémique : à propos de 10 cas. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
69
|
Razafindramaro N, Merle C, Messica O, Faure C, Barbat S, Mohn A, Haroche J, Ory JP. Histiocytose BRAF-muté : à propos de 2 observations personnelles, améliorées par le traitement spécifique. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
70
|
Abisror N, Fain O, Mekinian A, Lefevre G, Berezne A, Morati-Hafsaoui C, Dufour J, Haroche J, Jeandel P, Noel N, Lhote F, Kahn J. Angiœdèmes épisodiques avec hyperéosinophilie ou syndrome de Gleich : à propos de 29 observations. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.288] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
71
|
Marlet J, Ankri A, Charuel J, Ghillani-Dalbin P, Perret A, Martin-Toutain I, Haroche J, Amoura Z, Musset L, Miyara M. Anticorps anti-DFS70 et thrombophilie. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
72
|
Raphalen J, Haroche J, Waintraub X, Kerneis M, Cheikh-Khalifa R, Fouret P, Varnous S, Montalescot G, Guiochon Mantel A, Redheuil A, Cluzel P, Amoura Z, Cohen Aubart F. Le séquençage du gène de la transthyrétine est un examen rentable et non invasif qui peut être demandé en première intention devant une cardiopathie présumée amyloïde sans argument biologique sérique pour une amylose AL ou AA. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
73
|
Cohen Aubart F, Haroche J, De Risi T, Barkaoui M, Charlotte F, Sene T, Bernard C, Galicier L, Chaminade A, Hervier B, Kahn J, Tazi A, Donadieu J, Amoura Z. La maladie de Rosai-Dorfman-Destombes est une histiocytose inflammatoire polymorphe : étude phénotypique multicentrique de 47 patients. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.267] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
74
|
Bitoun S, Cohen Aubart F, Haroche J, Mathian A, Hie M, Boutin T, Arnaud L, Bouvry D, Borie R, Sacre K, Mahevas M, Hausfater P, Amoura Z. SAT0549 Methotrexate Versus Mycophenolate Mofetil in Neurosarcoidosis: A Retrospective Trial. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
75
|
Bitoun S, Cohen Aubart F, Haroche J, Psimaras D, Mathian A, Boutin D, Hie M, Viala K, Pottier C, Arnaud L, Hausfater P, Amoura Z. Étude comparative rétrospective de l’efficacité et de la tolérance du methotrexate versus mycophénolate mofétil dans les neurosarcoïdoses. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|